Association between p53 Gene Variants and Oral Cancer Susceptibility in Population from Gujarat, West India |
Patel, Kinjal R.
(Biochemistry Research Division)
Vajaria, Bhairavi N. (Biochemistry Research Division) Begum, Rasheedunnisa (Department of Biochemistry, The M. S. University of Baroda) Shah, Franky D. (Biochemistry Research Division) Patel, Jayendra B. (Biochemistry Research Division) Shukla, Shilin N. (The Gujarat Cancer and Research Institute) Patel, Prabhudas S. (Biochemistry Research Division) |
1 | Khaliq S, Hameed A, Khaliq T, et al (2000). P53 mutations, polymorphisms, and haplotypes in Pakistani ethnic groups and breast cancer patients. Genet Test, 4, 23-9. DOI ScienceOn |
2 | Kietthubthew S, Sriplung H, Au WW, Ishida T (2003). The p53Codon 72 polymorphism and risk of oral cancer in Southern Thailand. Asian Pac J Cancer Prev, 4, 209-14. |
3 | Kuroda Y, Nakao H, Ikemura K, Katoh T (2007). Association between the TP53 codon72 polymorphism and oral cancer risk and prognosis. Oral Oncol, 43, 1043-8. DOI ScienceOn |
4 | Lazar V, Hazard F, Bertin F, et al (1993). Simple sequence repeat polymorphism within the p53 gene. Oncogene, 8, 1703-5. |
5 | Lehman TA, Haffty BG, Carbone CJ, et al (2000). Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer. Cancer Res, 60, 1062-9. |
6 | Lozano G, Levine AJ (1991). Tissue-specific expression of p53in transgenic mice is regulated by intron sequences. Mol Carcinog, 4, 3-9. DOI ScienceOn |
7 | Matlashewski GJ, Tuck S, Pim D, et al (1987). Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol, 7, 961-3. |
8 | Mattick JS (1994). Introns: evolution and function. Curr Opin Genet Dev, 4, 823-31. DOI ScienceOn |
9 | Mitra S, Chatterjee S, Panda CK, et al (2003). Haplotype structure of TP53 locus in Indian population and possible association with head and neck cancer. Ann Hum Genet, 67, 26-34. DOI ScienceOn |
10 | Mitra S, Sikdar N, Misra C, et al (2005). Risk assessment of p53genotypes and haplotypes in tobacco-associated leukoplakia and oral cancer patients from eastern India. Int J Cancer, 117, 786-93. DOI ScienceOn |
11 | Mittal RD, George GP, Mishra J, Mittal T, Kapoor R (2011). Role of functional polymorphisms of p53 and p73 genes with the risk of prostate cancer in a case-control study from Northern India. Arch Med Res, 42, 122-7. DOI ScienceOn |
12 | Nagpal JK, Patnaik S, Das BR (2002). Prevalence of high-risk human papilloma virus types and its association with p53codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India. Int J Cancer, 97, 649-53. DOI ScienceOn |
13 | Ozeki C, Sawai Y, Shibata T, et al (2011). Cancer susceptibility polymorphism of p53 at codon 72 affects phosphorylation and degradation of p53 protein. J Biol Chem, 286, 18251-60. DOI ScienceOn |
14 | Pandith AA, Shah ZA, Khan NP, et al (2010). Role of TP53Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population. Cancer Genet Cytogenet, 203, 263-8. DOI ScienceOn |
15 | Paterson IC, Eveson JW, Prime SS (1996). Molecular changes in oral cancer may reflect aetiology and ethnic origin. Eur J Cancer B Oral Oncol, 32, 150-3. DOI ScienceOn |
16 | Pim D, Banks L (2004). p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer, 108, 196-9. DOI ScienceOn |
17 | Saini R, Tang TH, Zain RB, et al (2011). Significant association of high-risk human papillomavirus (HPV) but not of p53polymorphisms with oral squamous cell carcinomas in Malaysia. J Cancer Res Clin Oncol, 137, 311-20. DOI |
18 | Sameer S, Shah ZA, Syeed N, et al (2010). TP53 Pro47Ser and Arg72Pro polymorphisms and colorectal cancer predispostion in an ethinic Kashmiri population. Genet Mol Res, 9, 651-60. DOI ScienceOn |
19 | Schneider-Stock R, Mawrin C, Motsch C, et al (2004). Retention of the arginine allele in codon 72 of the p53 gene correlates with poor apoptosis in head and neck cancer. Am J Pathol, 164, 1233-41. DOI ScienceOn |
20 | Shamsher M, Montano X (1996). Analysis of intron 4 of the p53gene in human cutaneous melanoma. Gene, 176, 259-62. DOI ScienceOn |
21 | Sprague BL, Trentham-Dietz A, Garcia-Closas M, et al (2007). Genetic variation in TP53 and risk of breast cancer in a population-based case control study. Carcinogenesis, 28, 1680-6. DOI ScienceOn |
22 | Stephens M, Smith NJ, Donnelly P (2001). A new statistical method for haplotype reconstruction from population data. Am J Hum Genet, 68, 978-89. DOI ScienceOn |
23 | Storey A, Thomas M, Kalita A, et al (1998). Role of a p53polymorphism in the development of human papillomavirus-associated cancer. Nature, 393, 229-34. DOI ScienceOn |
24 | Suresh K, Chandiraasekar R, Kumar BL, Venkatesan R, Sasikala K (2010). No association between the TP53 codon 72 polymorphism and Head and Neck Cancer: A case-control study in a south Indian population. Asian Pac J Cancer Prev, 11, 1749-53. |
25 | Suresh K, Venkatesan R, Chandirasekar R, Kumar BL, Sasikala K (2011). Association of TP53 Arg72Pro polymorphic variants with breast cancer - a case control study in south Indian population. Biology and Medicine, 3, 15-22. |
26 | Tandle AT, Sanghvi V, Saranath D (2001). Determination of p53genotypes in oral cancer patients from India. Br J Cancer, 84, 739-42. DOI ScienceOn |
27 | Thomas M, Kalita A, Labrecque S, et al (1999). Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol, 19, 1092-100. |
28 | Whibley C, Pharoah PD, Hollstein M (2009). p53 polymorphisms: cancer implications. Nat Rev Cancer, 9, 95-107. DOI ScienceOn |
29 | Wang-Gohrke S, Weikel W, Risch H, et al (1999). Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations. Br J Cancer, 81, 179-83. DOI ScienceOn |
30 | Weston A, Wolff MS, Morabia A, et al (1998). True extended haplotypes of p53: indicators of breast cancer risk. Cancer Genet Cytogenet, 102, 153-4. DOI ScienceOn |
31 | Wu X, Zhao H, Amos CI, et al (2002). p53 Genotypes and haplotypes associated with lung cancer susceptibility and ethnicity. J Natl Cancer Inst, 94, 681-90. DOI ScienceOn |
32 | Zhu F, Dolle ME, Berton TR, et al (2010). Mouse models for the p53 R72P polymorphism mimic human phenotypes. Cancer Res, 70, 5851-9. DOI |
33 | Zhuo XL, Li Q, Zhou Y, et al (2009). Study on TP53 codon 72 polymorphisms with oral carcinoma susceptibility. Arch Med Res, 40, 625-34. DOI ScienceOn |
34 | Chakrabarti S, Dasgupta S, Roy S, et al (2001). Microsatellite instability in squamous cell carcinoma of head and neck from the Indian patient population. Int J Cancer, 92, 555-61. DOI ScienceOn |
35 | Avigad S, Barel D, Blau O, et al (1997). A novel germ line p53mutation in intron 6 in diverse childhood malignancies. Oncogene, 14, 1541-5. DOI ScienceOn |
36 | Azzam GA, Frank AK, Hollstein M, Murphy ME (2011). Tissue-specific apoptotic effects of the p53 codon 72 polymophism in a mouse model. Cell Cycle, 10, 1352-5. DOI |
37 | Beckman G, Birgander R, Sjalander A, et al (1994). Is p53polymorphism maintained by natural selection? Hum Hered, 44, 266-70. DOI ScienceOn |
38 | Beenken SW, Karsenty G, Raycroft L, Lozano G (1991). An intron binding protein is required for transformation ability of p53. Nucleic Acids Res, 19, 4747-52. DOI ScienceOn |
39 | Bergamaschi D, Gasco M, Hiller L, et al (2003). p53polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell, 3, 387-402. DOI ScienceOn |
40 | Chumakov PM, Jenkins JR (1991). BstNI/NciI polymorphism of the human p53 gene (TP53). Nucleic Acids Res, 19, 6969. |
41 | Dumont P, Leu JI, Della Pietra AC 3rd, George DL, Murphy M (2003). The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet, 33, 357-65. DOI ScienceOn |
42 | Felley-Bosco E, Weston A, Cawley HM, Bennett WP, Harris CC (1993). Functional studies of a germ-line polymorphism at codon 47 within the p53 gene. Am J Hum Genet, 53, 752-9. |
43 | Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: Globocan 2008. Int J Cancer, 127, 2893-917. DOI ScienceOn |
44 | Francisco G, Menezes PR, Eluf-Neto J, Chammas R (2011). Arg72Pro P53 polymorphism and cancer susceptibility: a comprehensive meta-analysis of 302 case-control studies. Int J Cancer, 129, 920-30. DOI ScienceOn |
45 | Hrstka R, Beranek M, Klocova K, Nenutil R, Vojtesek B (2009). Intronic polymorphisms in TP53 indicate lymph node metastasis in breast cancer. Oncol Rep, 22, 1205-11. |
46 | Frank AK, Leu JI, Zhou Y, et al (2011). The codon 72 polymorphism of p53 regulates interaction with NF-{kappa}B and transactivation of genes involved in immunity and inflammation. Mol Cell Biol, 31, 1201-13. DOI ScienceOn |
47 | Galli P, Cadoni G, Volante M, et al (2009). A case-control study on the combined effects of p53 and p73 polymorphisms on head and neck cancer risk in an Italian population. BMC Cancer, 9, 137. DOI ScienceOn |
48 | Gemignani F, Moreno V, Landi S, et al (2004). A TP53polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA. Oncogene, 23, 1954-6. DOI ScienceOn |
49 | Hsieh LL, Huang TH, Chen IH, et al (2005). p53 polymorphisms associated with mutations in and loss of heterozygosity of the p53 gene in male oral squamous cell carcinomas in Taiwan. Br J Cancer, 92, 30-5. DOI ScienceOn |
50 | Hu Z, Li C, Chen K, et al (2008). Single nucleotide polymorphisms in selected apoptotic genes and BPDE-induced apoptotic capacity in apparently normal primary lymphocytes: a genotype-phenotype correlation analysis. J Cancer Epidemiol, 2008, 147905. |
51 | Hu Z, Li X, Qu X, et al (2010). Intron 3 16 bp duplication polymorphism of TP53 contributes to cancer susceptibility: a meta-analysis. Carcinogenesis, 31, 643-7. DOI ScienceOn |
52 | Imyanitov EN, Togo AV, Hanson KP (2004). Searching for cancer-associated gene polymorphisms: promises and obstacles. Cancer Lett, 204, 3-14. DOI ScienceOn |
53 | Katiyar S, Thelma BK, Murthy NS, et al (2003). Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India. Mol Cell Biochem, 252, 117-24. DOI ScienceOn |